• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[袢利尿剂的药理特性及其临床效果]

[Pharmacological Properties of Loop Diuretics and Their Clinical Effects].

作者信息

Sakalauskienė G, Civinskienė G, Antuševas A, Civinskas P

机构信息

Lithuanian University of Health Sciences.

出版信息

Kardiologiia. 2018 Jan(1):72-83. doi: 10.18087/cardio.2018.1.10084.

DOI:10.18087/cardio.2018.1.10084
PMID:29466174
Abstract

Edematous states caused by an excessesive extracellular fluid retention are major components of cardiovascular and renal disorders including chronic kidney disease, nephrotic syndrome, and heart failure. The use of diuretic drugs from various groups including loop duiretics are important means of pharmacological correction of these clinical conditions. Moreover, diuretics used to lower bood pressure as a part of antihypertensive treatment, reduce cardiovascular events. The response of patients to the dose of a diuretic is reflected by a sigmoid dose-response curve which can be affected by changes of sodium content in the body. Loop diuretics may fail to control salt and water retention despite the use of appropriate doses. The main reasons for loop diuretic resistance may be determined by further reduction of glomerular filtration rate and reduced peak concentration of loop diuretics in primary urine. Chronic treatment with loop diuretics can cause compensatory hyperthrophy of epithelial cells along the ascending limb of the loop of Henle and thus decrease of its diuretic effect. The principles of avoiding this phenomenon are the restriction of sodium intake, correction of doses, timing and frequency of drug administration, and use of combination diuretic therapy. Loop diuretic - related adverse events that involve uricaemia and ototoxicity also should be taken into consideration.

摘要

细胞外液潴留过多引起的水肿状态是心血管和肾脏疾病的主要组成部分,包括慢性肾脏病、肾病综合征和心力衰竭。使用包括袢利尿剂在内的各类利尿剂是对这些临床病症进行药物纠正的重要手段。此外,利尿剂作为降压治疗的一部分用于降低血压,可减少心血管事件。患者对利尿剂剂量的反应由一条S形剂量反应曲线反映,该曲线可能会受到体内钠含量变化的影响。尽管使用了适当剂量的袢利尿剂,仍可能无法控制盐和水的潴留。袢利尿剂抵抗的主要原因可能是肾小球滤过率进一步降低以及袢利尿剂在原尿中的峰值浓度降低。长期使用袢利尿剂可导致亨氏袢升支上皮细胞代偿性肥大,从而降低其利尿效果。避免这种现象的原则包括限制钠摄入、调整剂量、给药时间和频率以及采用联合利尿剂治疗。还应考虑与袢利尿剂相关的不良事件,包括尿毒症和耳毒性。

相似文献

1
[Pharmacological Properties of Loop Diuretics and Their Clinical Effects].[袢利尿剂的药理特性及其临床效果]
Kardiologiia. 2018 Jan(1):72-83. doi: 10.18087/cardio.2018.1.10084.
2
In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.在伴有明显液体潴留的慢性心力衰竭中,静脉注射大剂量袢利尿剂是肾功能恶化的一个预测指标,尤其是在左心室收缩功能正常或仅轻度受损的心力衰竭患者中。
Minerva Cardioangiol. 2011 Dec;59(6):543-54. Epub 2011 Feb 18.
3
Mechanisms and management of diuretic resistance in congestive heart failure.充血性心力衰竭中利尿剂抵抗的机制与管理
Postgrad Med J. 2003 May;79(931):268-71. doi: 10.1136/pmj.79.931.268.
4
Unloading therapy by intravenous diuretic in chronic heart failure: a double-edged weapon?静脉利尿剂在慢性心力衰竭中的卸荷治疗:一把双刃剑?
J Cardiovasc Med (Hagerstown). 2010 Aug;11(8):571-4. doi: 10.2459/JCM.0b013e32833d37b9.
5
Loop diuretics, renal function and clinical outcome in patients with heart failure and reduced ejection fraction.射血分数降低的心力衰竭患者中袢利尿剂、肾功能与临床结局
Eur J Heart Fail. 2016 Mar;18(3):328-36. doi: 10.1002/ejhf.462. Epub 2015 Dec 23.
6
[Electrolyte and acid-base balance disorders in advanced chronic kidney disease].[晚期慢性肾脏病中的电解质和酸碱平衡紊乱]
Nefrologia. 2008;28 Suppl 3:87-93.
7
Management of loop diuretic resistance in the intensive care unit.重症监护病房中襻利尿剂抵抗的管理。
Am J Health Syst Pharm. 2009 Sep 15;66(18):1635-40. doi: 10.2146/ajhp090068.
8
[Value of aldosterone receptor blockade in diuretic therapy of patients with chronic heart failure].[醛固酮受体阻断在慢性心力衰竭患者利尿治疗中的价值]
Herz. 2002 Mar;27(2):135-49. doi: 10.1007/s00059-002-2352-0.
9
Diuretic Resistance.利尿剂抵抗
Am J Kidney Dis. 2017 Jan;69(1):136-142. doi: 10.1053/j.ajkd.2016.08.027. Epub 2016 Nov 1.
10
Resistance to loop diuretics. Why it happens and what to do about it.对袢利尿剂的抵抗。其发生原因及应对措施。
Drugs. 1985 Nov;30(5):427-43. doi: 10.2165/00003495-198530050-00003.